These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
259 related items for PubMed ID: 15145170
1. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study. Jeremic B, Milicic B, Grujicic D, Samardzic M, Antunovic V, Dagovic A, Aleksandrovic J. Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):509-14. PubMed ID: 15145170 [Abstract] [Full Text] [Related]
2. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW. Clin Cancer Res; 2003 Mar 01; 9(3):981-90. PubMed ID: 12631596 [Abstract] [Full Text] [Related]
3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
4. Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study. Brandes AA, Tosoni A, Vastola F, Pasetto LM, Coria B, Danieli D, Iuzzolino P, Gardiman M, Talacchi A, Ermani M. Cancer; 2004 Nov 01; 101(9):2079-85. PubMed ID: 15372474 [Abstract] [Full Text] [Related]
5. Efficacy and feasibility of procarbazine, ranimustine and vincristine chemotherapy, and the role of surgical resection in anaplastic oligodendroglioma. Yamamoto M, Iwaasa M, Nonaka M, Tsugu H, Nabeshima K, Fukushima T. Anticancer Res; 2005 Nov 01; 25(6A):3715-23. PubMed ID: 16302731 [Abstract] [Full Text] [Related]
6. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy]. Wu SX, Deng ML, Li QQ, Zhao C, Lu TX, Li FY, Cui NJ. Ai Zheng; 2004 Nov 01; 23(11 Suppl):1561-6. PubMed ID: 15566680 [Abstract] [Full Text] [Related]
7. [The effect of extent of tumor resection on the outcome of combined therapy in patients with glioblastoma multiforme]. Jeremić B, Grulicić D, Samardzić M, Antunović V, Joksimović M, Djurić Lj, Milicić B, Nikolić N. Srp Arh Celok Lek; 1997 Nov 01; 125(3-4):93-8. PubMed ID: 9221525 [Abstract] [Full Text] [Related]
8. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Levin VA, Prados MR, Wara WM, Davis RL, Gutin PH, Phillips TL, Lamborn K, Wilson CB. Int J Radiat Oncol Biol Phys; 1995 Apr 30; 32(1):75-83. PubMed ID: 7721642 [Abstract] [Full Text] [Related]
9. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas. Levin VA, Yung WK, Bruner J, Kyritsis A, Leeds N, Gleason MJ, Hess KR, Meyers CA, Ictech SA, Chang E, Maor MH. Int J Radiat Oncol Biol Phys; 2002 May 01; 53(1):58-66. PubMed ID: 12007942 [Abstract] [Full Text] [Related]
10. Fractionated stereotactic radiation therapy in the management of primary oligodendroglioma and oligoastrocytoma. Combs SE, Schulz-Ertner D, Thilmann C, Edler L, Debus J. Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):797-802. PubMed ID: 15936562 [Abstract] [Full Text] [Related]
11. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ. Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1147-52. PubMed ID: 15001257 [Abstract] [Full Text] [Related]
12. Combined treatment modality for anaplastic oligodendroglioma: a phase II study. Jeremic B, Shibamoto Y, Gruijicic D, Milicic B, Stojanovic M, Nikolic N, Dagovic A, Aleksandrovic J. J Neurooncol; 1999 Jun 15; 43(2):179-85. PubMed ID: 10533731 [Abstract] [Full Text] [Related]
13. [Long-term results of treatment in patients with oligodendrogliomas and oligoastrocytomas of the cerebral hemispheres]. Iun'pén V, Oliushin VE, Ulitin AIu, Maslova LN, Petrov AA. Zh Vopr Neirokhir Im N N Burdenko; 2008 Jun 15; (2):6-10; discussion 10-1. PubMed ID: 18720725 [Abstract] [Full Text] [Related]
14. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary JP, Fisher BJ, Kim H, Murtha AD, Bell EH, Won M, Mehta MP, Curran WJ. N Engl J Med; 2016 Apr 07; 374(14):1344-55. PubMed ID: 27050206 [Abstract] [Full Text] [Related]
15. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26). Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M. BMC Cancer; 2006 Oct 18; 6():247. PubMed ID: 17049083 [Abstract] [Full Text] [Related]
16. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial. Chen GY, Jiang GL, Wang LJ, Qian H, Fu XL, Yang H, Wu KL, Zhao S. Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):70-5. PubMed ID: 15629596 [Abstract] [Full Text] [Related]
17. Ependymal tumors in childhood. Agaoglu FY, Ayan I, Dizdar Y, Kebudi R, Gorgun O, Darendeliler E. Pediatr Blood Cancer; 2005 Sep 01; 45(3):298-303. PubMed ID: 15770637 [Abstract] [Full Text] [Related]
18. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma]. Zhou WN, Chen ZP, You C, Mu YG, Sai K, Zhang JY, Zhang XH, Cheng JJ, Xu HC. Ai Zheng; 2004 Nov 01; 23(11 Suppl):1555-60. PubMed ID: 15566679 [Abstract] [Full Text] [Related]
19. New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951. Gorlia T, Delattre JY, Brandes AA, Kros JM, Taphoorn MJ, Kouwenhoven MC, Bernsen HJ, Frénay M, Tijssen CC, Lacombe D, van den Bent MJ. Eur J Cancer; 2013 Nov 01; 49(16):3477-85. PubMed ID: 23896377 [Abstract] [Full Text] [Related]
20. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma. Yang SH, Hong YK, Yoon SC, Kim BS, Lee YS, Lee TK, Lee KS, Jeun SS, Kim MC, Park CK. Oncol Rep; 2007 Jun 01; 17(6):1359-64. PubMed ID: 17487391 [Abstract] [Full Text] [Related] Page: [Next] [New Search]